The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 49.91

+1.0%

Dec 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Sun Tzu

To: Sun Tzu who wrote (3472)	1/29/2022 10:55:51 AM
From: stuffbug	1 Recommendation Read Replies (3) of 10711

Someone brought BIB to my attention. It is a double levered ETF that tracks the Nasdaq Biotech Index (IBB). The IBB is not as volatile as the XBI. From its peak last July, the IBB has declined by 31%. Over the same time frame, XBI is off 40%. Looking to use a leveraged ETF for an intermediate term position. Since the double levered ETfs are far more forgiving on non-optimal entries, I may go with BIB.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next